FDA Import Refusal 112-2192253-9/1/22 — Novartis Pharmaceuticals Corporation
The FDA refused shipment 112-2192253-9/1/22 from Novartis Pharmaceuticals Corporation (United States) on Jul 16, 2006. The refused product falls under Drugs and Biologics — OXCARBAZEPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II). Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 16, 2006
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66NCL07 OXCARBAZEPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II)
- Charges
- 179